Sodium Iodide → 2-[2-(4-Cyclobutyl-piperazin-1-yl)-2-oxo-ethyl]-1,2,3,4-tetrahydro-isoquinoline-7-carboxylic acid methylamide
反応式
[CH3:1][NH:2][C:3]([C:5]1[CH:14]=[C:13]2[C:8]([CH2:9][CH2:10][NH:11][CH2:12]2)=[CH:7][CH:6]=1)=[O:4].Cl[CH:16]1[CH2:21][N:20]([CH:22]2[CH2:25][CH2:24][CH2:23]2)[CH2:19][CH2:18][NH:17]1.[C:26](N)(=[O:28])[CH3:27].C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>C(#N)C.O>[CH3:1][NH:2][C:3]([C:5]1[CH:14]=[C:13]2[C:8]([CH2:9][CH2:10][N:11]([CH2:27][C:26]([N:17]3[CH2:18][CH2:19][N:20]([CH:22]4[CH2:25][CH2:24][CH2:23]4)[CH2:21][CH2:16]3)=[O:28])[CH2:12]2)=[CH:7][CH:6]=1)=[O:4]参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a stirred solution of 1,2,3,4-tetrahydro-isoquinoline-7-carboxylic acid methylamide (96 mg, 0.5 mmol) in acetonitrile (3.0 ml) is added 2-chloro-(4-cyclobutyl-piperazine)-acetamide (109 mg, 0.5 mmol, 1.0 eq.), K2CO3 (138 mg, 1.0 mmol, 2.0 eq.), and NaI (10 mg). The resulting mixture is stirred at rt overnight. Water (10.0 ml) is added to quench the reaction, and the acetonitrile is evaporated. The residue is extracted with DCM (10 ml×3), and the combined organic phase is dried over sodium sulfate and concentrated. The residue is purified by PTLC (EtOAc/4% TEA plus 4% EtOH) to give the title compound. MS (+VE) m/z 371.1 (M++1).
後処理
- customto quench
- customthe reaction
- customthe acetonitrile is evaporated
- extractionThe residue is extracted with DCM (10 ml×3)
- dry with materialthe combined organic phase is dried over sodium sulfate
- concentrationconcentrated
- customThe residue is purified by PTLC (EtOAc/4% TEA plus 4% EtOH)
出典と根拠
- ORDレコード
- ord-6f2e90cbc2974026a0b23207e1508234
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07795262B2
反応ノート
読み込み中…